Pyridam Farma Tbk PT
IDX:PYFA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ozderici Gayrimenkul Yatirim Ortakligi AS
IST:OZGYO.E
|
TR |
|
K
|
Keystone Technology Co Ltd
SSE:605588
|
CN |
|
E
|
enGene Holdings Inc
NASDAQ:ENGN
|
CA |
|
Sol Gel Technologies Ltd
NASDAQ:SLGL
|
IL |
|
S
|
SRV Yhtiot Oyj
OMXH:SRV1V
|
FI |
|
Jewett-Cameron Trading Company Ltd
NASDAQ:JCTC
|
US |
Pyridam Farma Tbk PT
Other Current Assets
Pyridam Farma Tbk PT
Other Current Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Pyridam Farma Tbk PT
IDX:PYFA
|
Other Current Assets
Rp115B
|
CAGR 3-Years
41%
|
CAGR 5-Years
59%
|
CAGR 10-Years
41%
|
|
|
T
|
Tempo Scan Pacific Tbk PT
IDX:TSPC
|
Other Current Assets
Rp399.3B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
2%
|
CAGR 10-Years
5%
|
|
|
Kalbe Farma Tbk PT
IDX:KLBF
|
Other Current Assets
Rp1.1T
|
CAGR 3-Years
13%
|
CAGR 5-Years
19%
|
CAGR 10-Years
10%
|
|
|
Darya-Varia Laboratoria Tbk PT
IDX:DVLA
|
Other Current Assets
Rp50.4B
|
CAGR 3-Years
16%
|
CAGR 5-Years
1%
|
CAGR 10-Years
3%
|
|
|
Soho Global Health Tbk PT
IDX:SOHO
|
Other Current Assets
Rp458.2B
|
CAGR 3-Years
38%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
|
|
Kimia Farma Tbk PT
IDX:KAEF
|
Other Current Assets
Rp1.1T
|
CAGR 3-Years
13%
|
CAGR 5-Years
12%
|
CAGR 10-Years
13%
|
|
Pyridam Farma Tbk PT
Glance View
PT Pyridam Farma Tbk engages in the production and development of pharmaceutical medicines, and trading of medical supplies. The company is headquartered in Jakarta, Dki Jakarta and currently employs 1,539 full-time employees. The company went IPO on 2001-10-16. The firm operates through two segments: Pharmaceutical Products and Toll Manufacturing Services, and Medical Device Products. Its business consists of production and/or distribution of modern and traditional medicines and distribution of medical devices, such as laboratory equipment and PCR test kits. The company offers products across consumer health, prescription, pyfaesthetic and biomedilab categories. The company produces various kinds of pharmaceuticals products ranging from antibiotics, vitamins and health supplements. The firm offers its products in the form of effervescent tablets, capsules, caplets, syrups and creams. Its prescription production has several properties, such as anti-infection, anti-inflammatory, anti-parkinsonian, anti-epileptic, and other indications. The company provides toll manufacturing services to produce products owned by the Company’s partner companies in accordance with predetermined specifications.
See Also
What is Pyridam Farma Tbk PT's Other Current Assets?
Other Current Assets
115B
IDR
Based on the financial report for Sep 30, 2025, Pyridam Farma Tbk PT's Other Current Assets amounts to 115B IDR.
What is Pyridam Farma Tbk PT's Other Current Assets growth rate?
Other Current Assets CAGR 10Y
41%
Over the last year, the Other Current Assets growth was 48%. The average annual Other Current Assets growth rates for Pyridam Farma Tbk PT have been 41% over the past three years , 59% over the past five years , and 41% over the past ten years .
